SH-111

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSH-111
Drug Alias NameSH-111
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShorla Pharma Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLeukemia, T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A